- Home
- JAGX vs FOXO Comparison
JAGX vs FOXO Comparison
Compare JAGX & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- FOXO
- Stock Information
- Founded
- JAGX 2013
- FOXO 2019
- Country
- JAGX United States
- FOXO United States
- Employees
- JAGX N/A
- FOXO N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- JAGX Health Care
- FOXO Technology
- Exchange
- JAGX Nasdaq
- FOXO Nasdaq
- Market Cap
- JAGX 3.8M
- FOXO 3.9M
- IPO Year
- JAGX N/A
- FOXO N/A
- Fundamental
- Price
- JAGX $10.91
- FOXO $0.08
- Analyst Decision
- JAGX
- FOXO
- Analyst Count
- JAGX 0
- FOXO 0
- Target Price
- JAGX N/A
- FOXO N/A
- AVG Volume (30 Days)
- JAGX 211.5K
- FOXO 7.4M
- Earning Date
- JAGX 05-13-2025
- FOXO 04-15-2025
- Dividend Yield
- JAGX N/A
- FOXO N/A
- EPS Growth
- JAGX N/A
- FOXO N/A
- EPS
- JAGX N/A
- FOXO N/A
- Revenue
- JAGX $11,689,000.00
- FOXO $4,051,601.00
- Revenue This Year
- JAGX $38.22
- FOXO N/A
- Revenue Next Year
- JAGX $39.96
- FOXO N/A
- P/E Ratio
- JAGX N/A
- FOXO N/A
- Revenue Growth
- JAGX 19.75
- FOXO 2688.61
- 52 Week Low
- JAGX $4.02
- FOXO $0.07
- 52 Week High
- JAGX $540.00
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- JAGX 70.55
- FOXO 27.56
- Support Level
- JAGX $5.00
- FOXO $0.07
- Resistance Level
- JAGX $6.13
- FOXO $0.12
- Average True Range (ATR)
- JAGX 1.37
- FOXO 0.01
- MACD
- JAGX 0.94
- FOXO -0.00
- Stochastic Oscillator
- JAGX 60.12
- FOXO 17.72
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.